Lung Cancer
-
Fosun (Foritinib) – NSCLC | HongKong DengYue Medicine
-
Haiyitan (Glumetinib) – Lung Cancer (NSCLC) | HongKong DengYue Medicine
-
Andewei (Benmelstobart) – ES-SCLC | HongKong DengYue Medicine
-
Cyramza (Ramucirumab) – NSCLC | HongKong DengYue Medicine
-
Saimeina (Befotertinib) – NSCLC | HongKong DengYue Medicine
-
Mektovi (Binimetinib) – Melanoma | HongKong DengYue Medicine
-
Hernexeos (Zongertinib) – NSCLC | HongKong DengYue Medicine
-
Avastin (Bevacizumab) – mCRC & NSCLC | HongKong DengYue Medicine
-
Conmana (Icotinib) – NSCLC | HongKong DengYue Medicine
-
Xalkori (Crizotinib) – NSCLC | HongKong DengYue Medicine
-
Iressa (Gefitinib) – NSCLC | HongKong DengYue Medicine
-
Avida (Trastuzumab Rezetecan) – NSCLC | HongKong DengYue Medicine
-
Airuikai (Glecirasib Citrate) – NSCLC | HongKong DengYue Medicine
-
Aoyixin (Limertinib) – NSCLC | HongKong DengYue Medicine
-
Hycamtin (Topotecan Hydrochloride) – Malignancies | HongKong DengYue Medicine
-
ENHERTU (Trastuzumab Deruxtecan) – HER2-driven cancers | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights